查看购物车
  • Traditional Chinese
  • English
  • Japanese
类器官市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用、来源、产品、方法和地理位置
市场调查报告书
商品编码
1571361

类器官市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用、来源、产品、方法和地理位置

Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography
出版日期: | 出版商: The Insight Partners | 英文 236 Pages | 订单完成后即时交付

价格

类器官市场规模预计将从2023年的30.3亿美元成长到2031年的150.1亿美元；预计 2023 年至 2031 年复合年增长率为 22.3%。类器官市场的成长归因于对肿瘤建模和生物库的需求不断增加，以及个人化药物的大量采用。然而，缺乏熟练的专业人员和严格的安全法规阻碍了市场的成长。公司的关键发展可能为市场成长提供机会。

类器官市场已细分为5个主要地区：北美、欧洲、亚太地区、中东和非洲、南美洲和中美洲。北美主导着类器官市场。美国在北美类器官市场占据主要市场份额，其次是加拿大和墨西哥。

根据加拿大健康资讯研究所2023年1月公布的资料，在加拿大，从2012年到2021年，肾臟替代手术平均每年增加1.4%。 2021年共进行移植2750例，器官捐赠1328例。利用人类诱导的多能干细胞开发肾臟类器官代表了再生医学的重要进展。它们预计将用于疾病建模和药物发现，并可能适用于器官移植。此外，也向研究组织分配了一些资金，以鼓励类器官的发展。例如，多伦多大学的研究人员在 2019 年至 2021 年期间从 Medicine by Design 获得了近 2,731 万美元（2,100 万加元）的资助。此外，还向 Medicine by Design 提供了 1.483 亿美元（1.14 亿加元）的赠款，作为加拿大首个卓越研究基金。因此，提供资助是一项策略性倡议，旨在促进再生医学的变革性发现，并透过工程、医学和科学的融合加速其产生临床影响。市场参与者也注重有机成长策略，以巩固自己的立足点。 2022年4月，BC省儿童医院基金会在BC省儿童医院推出了新的干细胞研究技术。该医院的目标是在其细胞和再生医学中心将干细胞培养的所有方面整合到一台设备中并实现自动化。因此，在预测期内，对类器官开发的不断增长的投资预计将推动加拿大类器官市场的发展。

依应用分类，类器官市场洞察

根据应用，类器官市场分为发育生物学、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。 2023年，发育生物学疾病领域占最大市场份额；预计 2023 年至 2031 年复合年增长率将达到最高。发育生物学是对多细胞生物生长和发育过程的研究；这些过程主要由其基因控制。从培养的干细胞或组织发育而来的类器官可以转化为类似完整器官的体内解剖学和生理学的结构。人类类器官培养可用于研究人类发育和疾病模型，其分析深度与非人类模型生物体研究惯用的分析深度相同。随着技术的进步，3D生物列印已被证明在帮助器官发育方面具有巨大的潜力，因为透过3D列印建立类器官所需的时间比传统的组织培养方法少得多。源自患者的人类类器官的研究可能会在组织工程和再生医学等领域带来新的可能性，为药物开发研究中的临床前测试产生知识和工具。

发育生物学应用类器官市场的成长归因于类器官作为人类发育生物学主要研究工具的接受。此外，从胚胎干细胞生长的类器官可以提供对胚胎过程发育的完整理解和对干细胞发育的见解。

在进行类器官市场分析时确定和评估的主要参与者是 STEMCELL Technologies；分子器件有限责任公司； HUB Organoids BV（Hubrecht Organoid Technology）；定义生成；类器官治疗；赛默飞世尔科技公司；康宁公司；默克公司； InSphero； ACRO生物系统公司；和生物技术公司。

2022 年 11 月，ACROBiosystems 开发了一系列高品质的 ActiveMax 细胞因子，以支持类器官细胞培养研究。细胞因子，包括 EGF、Noggin、R-Spondin 1、FGF10、FGF2 和 Activin A，可作为类器官培养的生长因子，并已被证实可促进类器官生长。

2023 年 7 月，Molecular Devices, LLC 利用专有的生物反应器和生物製程技术，扩大了标准化、可用于分析的类器官的生产，扩大了其类器官产品线服务，以支持下一代药物发现。

2023 年 2 月，Thermo Fisher Scientific 和 Celltrio 合作为生物治疗客户带来全自动细胞培养系统。此次合作将 Thermo Scientific Momentum 工作流程调度软体与 Celltrio RoboCell细胞株自动化平台相集成，以满足高通量自动化细胞株培养和维护方面未满足的市场需求

投资者介绍、世界卫生组织、美国国立卫生研究院、美国食品药物管理局 (FDA) 药物评估与研究中心 (CDER)、美国劳工统计局是在准备报告时参考的一些主要二手来源。器官市场的报告。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：
  • PEST分析

第 4 章：类器官市场 - 主要市场动态

  • 类器官市场 - 主要市场动态
  • 市场驱动因素
    • 对肿瘤建模和生物样本库的需求不断增加
    • 个人化药物的采用激增
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 专注于药物发现活动
  • 未来趋势
    • 类器官和器官晶片的组合
  • 驱动因素和限制的影响：

第 5 章：类器官市场 - 全球市场分析

  • 类器官市场收入，2021-2031
  • 类器官市场预测分析

第 6 章：类器官市场分析 - 按类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 7 章：类器官市场分析 - 按应用

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 8 章：类器官市场分析 - 按来源

  • 多能干细胞
  • 器官特异性成体干细胞

第 9 章：类器官市场分析 - 按产品

  • 仪器仪表
  • 耗材
  • 服务

第 10 章：类器官市场分析 - 按方法

  • 微图案板
  • 超低连接板
  • 悬滴
  • 微滴/乳液
  • 其他的

第 11 章：类器官市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 概述
  • 类器官市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 13 章：公司简介

  • STEMCELL Technologies Inc
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology
  • Definigen
  • Organoid Therapeutics
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • Merck KGaA
  • InSphero
  • ACRO Biosystems.
  • Bio-Techne Corp
  • SUN bioscience SA
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc
  • Sartorius AG
  • 3D Biotek LLC
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd

第 14 章：附录

Product Code: TIPRE00017616

The organoids market size is expected to grow from US$ 3.03 billion in 2023 to US$ 15.01 billion by 2031; it is projected to register a CAGR of 22.3% during 2023-2031. The organoids market growth is attributed to the increasing demand for tumor modeling & biobanking, and a surging adoption of personalized drugs. However, the dearth of skilled professionals and stringent safety regulations hinder the growth of the market. Key developments by companies are likely to offer opportunities for market growth.

The organoids market has been segmented into the 5 major regions: North America, Europe, Asia Pacific, Middle East and Africa, South and Central America. North America dominates the organoids market. US held the major market share in the North America organoids market followed by Canada and Mexico.

In Canada, renal replacement procedures increased with an average rate of 1.4% per year from 2012 to 2021, as per the data published by the Canadian Institute for Health Information in January 2023. In the same period, organ donation and transplantation increased by 23%. A total of 2,750 transplantations occurred in 2021, while the count of organ donations was 1,328. The development of kidney organoids from human-induced pluripotent stem cells represents an essential advancement in regenerative medicine. They are expected to be used for disease modeling and drug discovery and might be applicable for organ transplantation. Moreover, several funds are allocated to research organizations to encourage the development of organoids. For instance, researchers at the University of Toronto received nearly US$ 27.31 million (CA$ 21 million) in funding from Medicine by Design during 2019-2021. Also, a US$ 148.3 million (CA$ 114 million) grant was provided to Medicine by Design as the Canada First Research Excellence Fund. Therefore, offering grants is a strategic initiative to catalyze transformative findings in regenerative medicine and accelerate them toward clinical impact through the convergence of engineering, medicine, and science. Market players are also focusing on organic growth strategies to strengthen their foothold. In April 2022, BC Children's Hospital Foundation launched new stem cell research technology at BC Children's Hospital. The hospital aims to combine and automate all aspects of stem cell culturing into a single piece of equipment at its Cellular and Regenerative Medicine Centre. Thus, the growing investment in the development of organoids is expected to fuel the organoids market in Canada over the forecast period.

By Application, Organoids Market-Based Insights

Based on application, the organoids market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031. Developmental biology is the study of processes involved in the growth and development of multicellular organisms; these processes are predominantly controlled by their genes. Organoids developed from stem cells or tissues in culture can be transformed into structures that resemble the in-vivo anatomy and physiology of intact organs. Human organoid cultures can be used to study human development and model diseases with the same depth of analysis that is customary for research with nonhuman model organisms. With technological advancements, 3D bioprinting have been shown to possess massive potential to aid in organ development, as the time required for building organoids through 3D printing is much less than traditional tissue culture methods. Studies enabled by patient-derived human organoids may lead to new possibilities in the fields such as tissue engineering and regenerative medicine, generating knowledge and tools for preclinical testing in drug development studies.

The growth of the organoids market for developmental biology applications is attributed to the acceptance of organoids as the primary investigative research tool in human developmental biology. Moreover, organoids grown from embryonic stem cells offer a complete understanding of embryonic process development and insights into stem cell development.

Key players identified and evaluated while performing organoids market analysis are STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation.

In Nov-2022, ACROBiosystems developed a series of high-quality ActiveMax cytokines to support research on organoid cell culturing. The cytokines, including EGF, Noggin, R-Spondin 1, FGF10, FGF2, and Activin A, serve as growth factors for organoid culture and have been verified to promote organoid growth.

In Jul-2023, Molecular Devices, LLC expanded its organoid line services to support next-generation drug discovery by scaling up the production of standardized, assay-ready organoids, leveraging proprietary bioreactor and bioprocess technology.

In Feb-2023, Thermo Fisher Scientific and Celltrio collaborated to bring a fully automated cell culture system to biotherapeutics customers. The collaboration will integrate the Thermo Scientific Momentum workflow scheduling software with the Celltrio RoboCell cell line automation platform to address the unmet market need for high-throughput automated cell line culturing and maintenance

Investor Presentation, World Health Organization, National Institutes of Health, Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA), US Bureau of Labor Statistics, are a few of the major secondary sources referred to while preparing the report on the organoids market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 PEST Analysis

4. Organoids Market - Key Market Dynamics

  • 4.1 Organoids Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Tumor Modeling and Biobanking
    • 4.2.2 Surging Adoption of Personalized Drugs
  • 4.3 Market Restraints
    • 4.3.1 Dearth of Skilled Professionals
  • 4.4 Market Opportunities
    • 4.4.1 Focus on Drug Discovery Activities
  • 4.5 Future Trends
    • 4.5.1 Combination of Organoids and Organ-on-a-Chip
  • 4.6 Impact of Drivers and Restraints:

5. Organoids Market - Global Market Analysis

  • 5.1 Organoids Market Revenue (US$ Million), 2021-2031
  • 5.2 Organoids Market Forecast Analysis

6. Organoids Market Analysis - by Type

  • 6.1 Intestine
    • 6.1.1 Overview
    • 6.1.2 Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Liver
    • 6.2.1 Overview
    • 6.2.2 Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Stomach
    • 6.3.1 Overview
    • 6.3.2 Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Pancreas
    • 6.4.1 Overview
    • 6.4.2 Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.5 Lung
    • 6.5.1 Overview
    • 6.5.2 Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.6 Brain
    • 6.6.1 Overview
    • 6.6.2 Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.7 Kidney
    • 6.7.1 Overview
    • 6.7.2 Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.8 Others
    • 6.8.1 Overview
    • 6.8.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

7. Organoids Market Analysis - by Application

  • 7.1 Developmental Biology Disease
    • 7.1.1 Overview
    • 7.1.2 Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Pathology of Infectious Disease
    • 7.2.1 Overview
    • 7.2.2 Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Regenerative Medicine
    • 7.3.1 Overview
    • 7.3.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Drug Toxicity and Efficacy Testing
    • 7.4.1 Overview
    • 7.4.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Drug Discovery and Personalized Medicine
    • 7.5.1 Overview
    • 7.5.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Market Analysis - by Source

  • 8.1 Pluripotent Stem Cells
    • 8.1.1 Overview
    • 8.1.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Organ Specific Adult Stem Cell
    • 8.2.1 Overview
    • 8.2.2 Organ Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Market Analysis - by Offerings

  • 9.1 Instruments
    • 9.1.1 Overview
    • 9.1.2 Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Consumables
    • 9.2.1 Overview
    • 9.2.2 Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Services
    • 9.3.1 Overview
    • 9.3.2 Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Market Analysis - by Method

  • 10.1 Micropatterned Plates
    • 10.1.1 Overview
    • 10.1.2 Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Ultralow Attachment Plates
    • 10.2.1 Overview
    • 10.2.2 Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Hanging Drop
    • 10.3.1 Overview
    • 10.3.2 Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Microdroplet/Emulsion
    • 10.4.1 Overview
    • 10.4.2 Microdroplet/Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

11. Organoids Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Organoids Market Overview
    • 11.2.2 North America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.2.3 North America: Organoids Market Breakdown, by Type
      • 11.2.3.1 North America: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.2.4 North America: Organoids Market Breakdown, by Application
      • 11.2.4.1 North America: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.2.5 North America: Organoids Market Breakdown, by Source
      • 11.2.5.1 North America: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.2.6 North America: Organoids Market Breakdown, by Offerings
      • 11.2.6.1 North America: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.2.7 North America: Organoids Market Breakdown, by Method
      • 11.2.7.1 North America: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.2.8 North America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.2.8.1 North America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.2.8.2 United States: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.8.2.1 United States: Organoids Market Breakdown, by Type
        • 11.2.8.2.2 United States: Organoids Market Breakdown, by Application
        • 11.2.8.2.3 United States: Organoids Market Breakdown, by Source
        • 11.2.8.2.4 United States: Organoids Market Breakdown, by Offerings
        • 11.2.8.2.5 United States: Organoids Market Breakdown, by Method
      • 11.2.8.3 Canada: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.8.3.1 Canada: Organoids Market Breakdown, by Type
        • 11.2.8.3.2 Canada: Organoids Market Breakdown, by Application
        • 11.2.8.3.3 Canada: Organoids Market Breakdown, by Source
        • 11.2.8.3.4 Canada: Organoids Market Breakdown, by Offerings
        • 11.2.8.3.5 Canada: Organoids Market Breakdown, by Method
      • 11.2.8.4 Mexico: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.8.4.1 Mexico: Organoids Market Breakdown, by Type
        • 11.2.8.4.2 Mexico: Organoids Market Breakdown, by Application
        • 11.2.8.4.3 Mexico: Organoids Market Breakdown, by Source
        • 11.2.8.4.4 Mexico: Organoids Market Breakdown, by Offerings
        • 11.2.8.4.5 Mexico: Organoids Market Breakdown, by Method
  • 11.3 Europe
    • 11.3.1 Europe Organoids Market Overview
    • 11.3.2 Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.3.3 Europe: Organoids Market Breakdown, by Type
      • 11.3.3.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.3.4 Europe: Organoids Market Breakdown, by Application
      • 11.3.4.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.3.5 Europe: Organoids Market Breakdown, by Source
      • 11.3.5.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.3.6 Europe: Organoids Market Breakdown, by Offerings
      • 11.3.6.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.3.7 Europe: Organoids Market Breakdown, by Method
      • 11.3.7.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.3.8 Europe: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.3.8.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.3.8.2 Germany: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.2.1 Germany: Organoids Market Breakdown, by Type
        • 11.3.8.2.2 Germany: Organoids Market Breakdown, by Application
        • 11.3.8.2.3 Germany: Organoids Market Breakdown, by Source
        • 11.3.8.2.4 Germany: Organoids Market Breakdown, by Offerings
        • 11.3.8.2.5 Germany: Organoids Market Breakdown, by Method
      • 11.3.8.3 France: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.3.1 France: Organoids Market Breakdown, by Type
        • 11.3.8.3.2 France: Organoids Market Breakdown, by Application
        • 11.3.8.3.3 France: Organoids Market Breakdown, by Source
        • 11.3.8.3.4 France: Organoids Market Breakdown, by Offerings
        • 11.3.8.3.5 France: Organoids Market Breakdown, by Method
      • 11.3.8.4 United Kingdom: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.4.1 United Kingdom: Organoids Market Breakdown, by Type
        • 11.3.8.4.2 United Kingdom: Organoids Market Breakdown, by Application
        • 11.3.8.4.3 United Kingdom: Organoids Market Breakdown, by Source
        • 11.3.8.4.4 United Kingdom: Organoids Market Breakdown, by Offerings
        • 11.3.8.4.5 United Kingdom: Organoids Market Breakdown, by Method
      • 11.3.8.5 Italy: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.5.1 Italy: Organoids Market Breakdown, by Type
        • 11.3.8.5.2 Italy: Organoids Market Breakdown, by Application
        • 11.3.8.5.3 Italy: Organoids Market Breakdown, by Source
        • 11.3.8.5.4 Italy: Organoids Market Breakdown, by Offerings
        • 11.3.8.5.5 Italy: Organoids Market Breakdown, by Method
      • 11.3.8.6 Spain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.6.1 Spain: Organoids Market Breakdown, by Type
        • 11.3.8.6.2 Spain: Organoids Market Breakdown, by Application
        • 11.3.8.6.3 Spain: Organoids Market Breakdown, by Source
        • 11.3.8.6.4 Spain: Organoids Market Breakdown, by Offerings
        • 11.3.8.6.5 Spain: Organoids Market Breakdown, by Method
      • 11.3.8.7 Rest of Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.8.7.1 Rest of Europe: Organoids Market Breakdown, by Type
        • 11.3.8.7.2 Rest of Europe: Organoids Market Breakdown, by Application
        • 11.3.8.7.3 Rest of Europe: Organoids Market Breakdown, by Source
        • 11.3.8.7.4 Rest of Europe: Organoids Market Breakdown, by Offerings
        • 11.3.8.7.5 Rest of Europe: Organoids Market Breakdown, by Method
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Organoids Market Overview
    • 11.4.2 Asia Pacific: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.4.3 Asia Pacific: Organoids Market Breakdown, by Type
      • 11.4.3.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.4.4 Asia Pacific: Organoids Market Breakdown, by Application
      • 11.4.4.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.4.5 Asia Pacific: Organoids Market Breakdown, by Source
      • 11.4.5.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.4.6 Asia Pacific: Organoids Market Breakdown, by Offerings
      • 11.4.6.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.4.7 Asia Pacific: Organoids Market Breakdown, by Method
      • 11.4.7.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.4.8 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.4.8.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.4.8.2 Japan: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.2.1 Japan: Organoids Market Breakdown, by Type
        • 11.4.8.2.2 Japan: Organoids Market Breakdown, by Application
        • 11.4.8.2.3 Japan: Organoids Market Breakdown, by Source
        • 11.4.8.2.4 Japan: Organoids Market Breakdown, by Offerings
        • 11.4.8.2.5 Japan: Organoids Market Breakdown, by Method
      • 11.4.8.3 China: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.3.1 China: Organoids Market Breakdown, by Type
        • 11.4.8.3.2 China: Organoids Market Breakdown, by Application
        • 11.4.8.3.3 China: Organoids Market Breakdown, by Source
        • 11.4.8.3.4 China: Organoids Market Breakdown, by Offerings
        • 11.4.8.3.5 China: Organoids Market Breakdown, by Method
      • 11.4.8.4 India: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.4.1 India: Organoids Market Breakdown, by Type
        • 11.4.8.4.2 India: Organoids Market Breakdown, by Application
        • 11.4.8.4.3 India: Organoids Market Breakdown, by Source
        • 11.4.8.4.4 India: Organoids Market Breakdown, by Offerings
        • 11.4.8.4.5 India: Organoids Market Breakdown, by Method
      • 11.4.8.5 South Korea: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.5.1 South Korea: Organoids Market Breakdown, by Type
        • 11.4.8.5.2 South Korea: Organoids Market Breakdown, by Application
        • 11.4.8.5.3 South Korea: Organoids Market Breakdown, by Source
        • 11.4.8.5.4 South Korea: Organoids Market Breakdown, by Offerings
        • 11.4.8.5.5 South Korea: Organoids Market Breakdown, by Method
      • 11.4.8.6 Australia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.6.1 Australia: Organoids Market Breakdown, by Type
        • 11.4.8.6.2 Australia: Organoids Market Breakdown, by Application
        • 11.4.8.6.3 Australia: Organoids Market Breakdown, by Source
        • 11.4.8.6.4 Australia: Organoids Market Breakdown, by Offerings
        • 11.4.8.6.5 Australia: Organoids Market Breakdown, by Method
      • 11.4.8.7 Rest of APAC: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.8.7.1 Rest of APAC: Organoids Market Breakdown, by Type
        • 11.4.8.7.2 Rest of APAC: Organoids Market Breakdown, by Application
        • 11.4.8.7.3 Rest of APAC: Organoids Market Breakdown, by Source
        • 11.4.8.7.4 Rest of APAC: Organoids Market Breakdown, by Offerings
        • 11.4.8.7.5 Rest of APAC: Organoids Market Breakdown, by Method
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Organoids Market Overview
    • 11.5.2 Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.5.3 Middle East and Africa: Organoids Market Breakdown, by Type
      • 11.5.3.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.5.4 Middle East and Africa: Organoids Market Breakdown, by Application
      • 11.5.4.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.5.5 Middle East and Africa: Organoids Market Breakdown, by Source
      • 11.5.5.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.5.6 Middle East and Africa: Organoids Market Breakdown, by Offerings
      • 11.5.6.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.5.7 Middle East and Africa: Organoids Market Breakdown, by Method
      • 11.5.7.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.5.8 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.5.8.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.5.8.2 Saudi Arabia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.2.1 Saudi Arabia: Organoids Market Breakdown, by Type
        • 11.5.8.2.2 Saudi Arabia: Organoids Market Breakdown, by Application
        • 11.5.8.2.3 Saudi Arabia: Organoids Market Breakdown, by Source
        • 11.5.8.2.4 Saudi Arabia: Organoids Market Breakdown, by Offerings
        • 11.5.8.2.5 Saudi Arabia: Organoids Market Breakdown, by Method
      • 11.5.8.3 South Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.3.1 South Africa: Organoids Market Breakdown, by Type
        • 11.5.8.3.2 South Africa: Organoids Market Breakdown, by Application
        • 11.5.8.3.3 South Africa: Organoids Market Breakdown, by Source
        • 11.5.8.3.4 South Africa: Organoids Market Breakdown, by Offerings
        • 11.5.8.3.5 South Africa: Organoids Market Breakdown, by Method
      • 11.5.8.4 United Arab Emirates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.4.1 United Arab Emirates: Organoids Market Breakdown, by Type
        • 11.5.8.4.2 United Arab Emirates: Organoids Market Breakdown, by Application
        • 11.5.8.4.3 United Arab Emirates: Organoids Market Breakdown, by Source
        • 11.5.8.4.4 United Arab Emirates: Organoids Market Breakdown, by Offerings
        • 11.5.8.4.5 United Arab Emirates: Organoids Market Breakdown, by Method
      • 11.5.8.5 Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.8.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type
        • 11.5.8.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application
        • 11.5.8.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source
        • 11.5.8.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offerings
        • 11.5.8.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Method
  • 11.6 South and Central America
    • 11.6.1 South and Central America Organoids Market Overview
    • 11.6.2 South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.6.3 South and Central America: Organoids Market Breakdown, by Type
      • 11.6.3.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Type
    • 11.6.4 South and Central America: Organoids Market Breakdown, by Application
      • 11.6.4.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Application
    • 11.6.5 South and Central America: Organoids Market Breakdown, by Source
      • 11.6.5.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Source
    • 11.6.6 South and Central America: Organoids Market Breakdown, by Offerings
      • 11.6.6.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Offerings
    • 11.6.7 South and Central America: Organoids Market Breakdown, by Method
      • 11.6.7.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Method
    • 11.6.8 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.6.8.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country
      • 11.6.8.2 Brazil: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.8.2.1 Brazil: Organoids Market Breakdown, by Type
        • 11.6.8.2.2 Brazil: Organoids Market Breakdown, by Application
        • 11.6.8.2.3 Brazil: Organoids Market Breakdown, by Source
        • 11.6.8.2.4 Brazil: Organoids Market Breakdown, by Offerings
        • 11.6.8.2.5 Brazil: Organoids Market Breakdown, by Method
      • 11.6.8.3 Argentina: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.8.3.1 Argentina: Organoids Market Breakdown, by Type
        • 11.6.8.3.2 Argentina: Organoids Market Breakdown, by Application
        • 11.6.8.3.3 Argentina: Organoids Market Breakdown, by Source
        • 11.6.8.3.4 Argentina: Organoids Market Breakdown, by Offerings
        • 11.6.8.3.5 Argentina: Organoids Market Breakdown, by Method
      • 11.6.8.4 Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.8.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type
        • 11.6.8.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application
        • 11.6.8.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source
        • 11.6.8.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offerings
        • 11.6.8.4.5 Rest of South and Central America: Organoids Market Breakdown, by Method

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Organoids Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 STEMCELL Technologies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Molecular Devices, LLC.
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hubrecht Organoid Technology
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Definigen
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Organoid Therapeutics
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Thermo Fisher Scientific Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Merck KGaA
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 InSphero
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ACRO Biosystems.
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments
  • 13.12 SUN bioscience SA
    • 13.12.1 Key Facts
    • 13.12.2 Business Description
    • 13.12.3 Products and Services
    • 13.12.4 Financial Overview
    • 13.12.5 SWOT Analysis
    • 13.12.6 Key Developments
  • 13.13 ORGANOID SCIENCES Co., Ltd.
    • 13.13.1 Key Facts
    • 13.13.2 Business Description
    • 13.13.3 Products and Services
    • 13.13.4 Financial Overview
    • 13.13.5 SWOT Analysis
    • 13.13.6 Key Developments
  • 13.14 Crown Bioscience Inc
    • 13.14.1 Key Facts
    • 13.14.2 Business Description
    • 13.14.3 Products and Services
    • 13.14.4 Financial Overview
    • 13.14.5 SWOT Analysis
    • 13.14.6 Key Developments
  • 13.15 Sartorius AG
    • 13.15.1 Key Facts
    • 13.15.2 Business Description
    • 13.15.3 Products and Services
    • 13.15.4 Financial Overview
    • 13.15.5 SWOT Analysis
    • 13.15.6 Key Developments
  • 13.16 3D Biotek LLC
    • 13.16.1 Key Facts
    • 13.16.2 Business Description
    • 13.16.3 Products and Services
    • 13.16.4 Financial Overview
    • 13.16.5 SWOT Analysis
    • 13.16.6 Key Developments
  • 13.17 Prellis Biologics Inc.
    • 13.17.1 Key Facts
    • 13.17.2 Business Description
    • 13.17.3 Products and Services
    • 13.17.4 Financial Overview
    • 13.17.5 SWOT Analysis
    • 13.17.6 Key Developments
  • 13.18 3Dnamics Inc.
    • 13.18.1 Key Facts
    • 13.18.2 Business Description
    • 13.18.3 Products and Services
    • 13.18.4 Financial Overview
    • 13.18.5 SWOT Analysis
    • 13.18.6 Key Developments
  • 13.19 Cellesce Ltd
    • 13.19.1 Key Facts
    • 13.19.2 Business Description
    • 13.19.3 Products and Services
    • 13.19.4 Financial Overview
    • 13.19.5 SWOT Analysis
    • 13.19.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners

List Of Tables

  • Table 1. Organoids Market Segmentation
  • Table 2. Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Source
  • Table 6. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Offerings
  • Table 7. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Method
  • Table 8. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 9. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 11. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 12. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 13. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 14. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 15. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 16. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 17. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 18. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 19. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 20. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 22. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 23. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 24. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 27. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 28. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 29. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 30. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 31. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 32. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 33. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 34. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 35. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 36. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 37. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 38. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 39. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 40. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 41. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 42. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 43. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 44. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 45. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 46. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 47. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 48. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 49. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 50. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 51. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 52. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 53. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 54. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 55. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 56. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 57. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 58. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 59. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 60. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 63. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 64. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 65. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 66. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 67. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 68. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 69. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 70. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 71. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 72. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 73. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 74. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 75. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 76. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 77. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 79. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 80. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 81. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 82. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 83. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 84. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 85. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 86. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 87. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 88. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 89. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 90. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 91. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 92. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 93. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 94. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 95. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 96. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 97. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 98. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 99. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 100. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 101. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 102. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 103. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 104. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 105. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 106. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 107. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 108. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 109. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 110. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 111. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 112. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 113. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 114. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 115. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 116. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 117. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 118. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 119. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 120. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 121. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 122. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 123. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 124. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 125. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 126. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 127. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 128. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 129. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 130. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 131. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 132. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 133. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 134. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 135. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 136. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 137. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 138. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 139. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 140. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 141. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 142. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 143. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 144. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 145. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 146. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offerings
  • Table 147. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 148. Recent Organic Growth Strategies in Organoids Market
  • Table 149. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Organoids Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Organoids Market Share (%) - by Offerings (2023 and 2031)
  • Figure 25. Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Microdroplet/Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Organoids Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 35. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. North America: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 37. North America: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 38. North America: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 39. North America: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 40. North America: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 41. North America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Europe: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 47. Europe: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 48. Europe: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 49. Europe: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 50. Europe: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 51. Europe: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 52. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. France: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 58. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. Asia Pacific: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 60. Asia Pacific: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 61. Asia Pacific: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 62. Asia Pacific: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 63. Asia Pacific: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 64. Asia Pacific: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 65. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 66. China: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. India: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 68. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 69. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Middle East and Africa: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 73. Middle East and Africa: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 74. Middle East and Africa: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 75. Middle East and Africa: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 76. Middle East and Africa: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 77. Middle East and Africa: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 78. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 79. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 80. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 81. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 82. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 83. South and Central America: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 84. South and Central America: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 85. South and Central America: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 86. South and Central America: Organoids Market Breakdown, by Offerings (2023 and 2031)
  • Figure 87. South and Central America: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 88. South and Central America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 89. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 90. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 91. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 92. Growth Strategies in Organoids Market